1st Jul 2014 08:05
LONDON (Alliance News) - Omega Diagnostics Group PLC said Tuesday it is one of the collaborating partners with the Groupe Speciale Mobile Association which will work to connect the mobile and health industries to develop commercially sustainable mHealth services in Sub-Saharan Africa.
The collaboration, announced in Johannesburg Monday, will connect the mobile and health industries to create mHealth services that meet public health needs.
Omega, a medical diagnostics company focused on allergy, food intolerance and infectious disease, has developed a mobile application in connection with its Visitect CD4 test which is currently undergoing beta evaluations in Kenya and India. The app will be used to support the transmission of results from remote village locations to databases controlled by the Ministries of Health.
"Current lab based static diagnostics tools are unable to meet growing patients' needs as countries step up their HIV treatment programmes in conjunction with the decentralisation of CD4 testing. Multi-layer partnerships for mHealth smartphone applications are poised to become an essential foundation in the bridge to augment the continuum of care to the neediest patients, whilst also providing management information and real time surveillance data, " said CEO of Omega Andrew Shepherd said.
Shares in Omega Diagnostics were trading 2.22% higher at 19.55 pence per share Tuesday morning.
By Alice Attwood; [email protected]; @AliceAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
ODX.L